“RFK Jr. just gave his and her stock a shake-up.” Should you follow the rally here?
Shares of Hims & Hers Health (HIMS) are extending gains on April 16 after HHS Secretary Robert F. Kennedy Jr. said the Food and Drug Administration (FDA) is considering lifting restrictions on more than a half-dozen peptides. Following this rise, HIMS is trading slightly below its 100-day moving average (MA), and a clear break above…